Artificial Intelligence

Biointron Reports Wet-Lab Validation Results for Molence Bio's AI-Designed Mol-1 Antibodies Using RushDATA

· GlobeWire Daily Editorial Desk · Source: www.prnewswire.com

2 min read

Key takeawaysBiointron Biological USA Inc. reported the results of wet-lab validation assays for AI-designed antibodies generated by Molence Bio's Mol-1 project. Using its RushDATA service, Biointron evaluated developability properties for candidates designed by the open model.
RushDATA™ Enables Wet-Lab Validation of AI-Designed Antibodies Generated by Molence Bio's Mol-1

Image: Biointron · Photo source · Resized and letterboxed to 16:9; no AI generation

Biointron Biological USA Inc. reported the results of wet-lab validation assays for AI-designed antibodies generated by Molence Bio's Mol-1 project. Using its RushDATA service, Biointron evaluated developability properties for candidates designed by the open model.

According to the announcement published on November 13, 2026, 23 out of 30 AI-designed candidates met at least three of the four tested developability criteria.

Developability Assessment and Benchmarking

AI-designed antibodies require experimental validation to confirm properties related to manufacturability and safety. Biointron conducted developability panels on VHH-Fc candidates from Molence Bio, measuring:

  • Hydrophobicity
  • Thermal stability
  • Self-interaction
  • Non-specific binding

The assays were benchmarked against established reference antibodies such as infliximab, bevacizumab, bococizumab, gantenerumab, and trastuzumab to compare the computational designs directly with approved and clinical-stage molecules.

Role of the RushDATA Platform

RushDATA is Biointron's wet-lab validation service designed for AI-generated antibodies. The platform offers:

  • High-throughput expression capabilities reported at over 10,000 antibodies per day
  • Turnaround times starting from 2 days for cell-free expression or 3 days for CHO expression
  • Binding affinity measurements using BLI or SPR
  • Developability profiling using techniques like DSF, PSR-BVP, and AC-SINS

Results are provided as structured datasets with API access intended to feed back into subsequent rounds of AI-guided model design.

Background on Mol-1 and Verification

Molence Bio's Mol-1 project aims at antibody-antigen structure prediction and functional nanobody design. Researchers and interested parties can access the model weights via the official GitHub repository at https://github.com/molence/Mol-1

To verify the original announcement and learn more about the validation platform, readers can consult the official press release on PR Newswire or visit the Biointron RushDATA portal at https://www.biointron.com/antibody-production/rushdata.html

Share this article
Read the original source: RushDATA™ Enables Wet-Lab Validation of AI-Designed Antibodies Generated by Molence Bio's Mol-1

AI-assisted reporting; source claims are attributed and have not been independently verified.

About the author

GlobeWire Daily Editorial Desk — AI-assisted news based on attributed published sources.

More to read